Insider · CIK 0001253886

ENRIGHT PATRICK G

Reports to the SEC for 25 companies · DUBLIN 4

sec.gov

Transactions

Companies

Filings

CIK

0001253886

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	JAZZJazz Pharmaceuticals plcF Tax Payment	Director	FTax Payment	−14 sh	$244.64	−$3,425.02	22,970
2026-08-31	JAZZJazz Pharmaceuticals plcF Tax Payment	Director	FTax Payment	−1,692 sh	$241.39	−$408K	21,278
2026-08-05	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+1,605 sh	—	—	22,984
2026-06-15	ZBIOZenas BioPharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2026-06-10	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2026-05-21	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.1K sh	—	—	17,084
2026-02-05	MANEVeradermics, Inc · Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.24M sh	—	—	0
2026-02-05	MANEVeradermics, IncC Conversion	Director, 10% Owner	CConversion	+1.24M sh	—	—	1,236,631
2026-02-05	MANEVeradermics, IncC Conversion	Director, 10% Owner	CConversion	+1.17M sh	—	—	1,171,121
2026-02-05	MANEVeradermics, IncP Purchase	Director, 10% Owner	PPurchase	+882K sh	$17.00	+$15M	2,053,474
2026-02-05	MANEVeradermics, IncP Purchase	Director, 10% Owner	PPurchase	+193K sh	$17.00	+$3.27M	2,600,399
2026-02-05	MANEVeradermics, Inc · Series C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.17M sh	—	—	0
2026-02-05	MANEVeradermics, Inc · Series C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.17M sh	—	—	0
2026-02-05	MANEVeradermics, IncC Conversion	Director, 10% Owner	CConversion	+1.17M sh	—	—	2,407,752
2026-02-03	MANEVeradermics, Inc · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+45.1K sh	—	—	45,131
2025-12-11	VERAVera Therapeutics, Inc.P Purchase	Director	PPurchase	+5,882 sh	$42.50	+$250K	5,882
2025-10-09	ZBIOZenas BioPharma, Inc.P Purchase	Director	PPurchase	+105K sh	$19.00	+$2M	1,832,669
2025-10-09	ZBIOZenas BioPharma, Inc.P Purchase	Director	PPurchase	+12K sh	$20.85	+$250K	11,990
2025-08-18	JAZZJazz Pharmaceuticals plcJ Other	Director	JOther	−5,000 sh	—	—	21,379
2025-08-08	JAZZJazz Pharmaceuticals plcF Tax Payment	Director	FTax Payment	−1,805 sh	$111.25	−$201K	26,379
2025-08-07	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+3,507 sh	—	—	28,184
2025-06-24	VERAVera Therapeutics, Inc.P Purchase	Director	PPurchase	+13.5K sh	$22.35	+$303K	1,797,619
2025-06-24	VERAVera Therapeutics, Inc.P Purchase	Director	PPurchase	+27.1K sh	$22.35	+$605K	3,596,593
2025-06-23	VERAVera Therapeutics, Inc.P Purchase	Director	PPurchase	+69.8K sh	$20.87	+$1.46M	1,784,083
2025-06-23	VERAVera Therapeutics, Inc.P Purchase	Director	PPurchase	+140K sh	$20.87	+$2.91M	3,569,522
2025-06-10	ZBIOZenas BioPharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2025-06-05	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2025-05-14	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2024-09-27	BIOABioAge Labs, Inc.P Purchase	Director	PPurchase	+400K sh	$18.00	+$7.2M	1,710,589
2024-09-27	BIOABioAge Labs, Inc.C Conversion	Director	CConversion	+1.31M sh	—	—	1,310,589
2024-09-27	BIOABioAge Labs, Inc. · Series D Preferred StockC Conversion	Director	CConversion	−5.85M sh	—	—	0
2024-09-25	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-09-16	ZBIOZenas BioPharma, Inc. · Series C Convertible Preferred StockC Conversion	Director	CConversion	−2.9M sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc. · Series C Convertible Preferred StockC Conversion	Director	CConversion	−8.71M sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc. · Series B Convertible Preferred StockC Conversion	Director	CConversion	−6.28M sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc.P Purchase	Director	PPurchase	+440K sh	$17.00	+$7.48M	774,530
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	Director	CConversion	+335K sh	—	—	334,530
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	Director	CConversion	+1M sh	—	—	1,727,404
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	Director	CConversion	+724K sh	—	—	723,812
2024-09-12	ZBIOZenas BioPharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37K sh	—	—	37,000
2024-08-02	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+3,731 sh	—	—	24,677
2024-05-15	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2023-08-14	JAZZJazz Pharmaceuticals plcS Sale	Director	SSale	−1,241 sh	$138.16	−$171K	20,946
2023-08-11	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+3,075 sh	—	—	22,187
2023-05-10	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2023-02-06	VERAVera Therapeutics, Inc.P Purchase	Director	PPurchase	+1.71M sh	$7.00	+$12M	1,714,285
2022-11-22	JAZZJazz Pharmaceuticals plcS Sale	Director	SSale	−2,069 sh	$149.90	−$310K	19,112
2022-11-22	JAZZJazz Pharmaceuticals plcS Sale	Director	SSale	−2,905 sh	$149.18	−$433K	21,181
2022-11-22	JAZZJazz Pharmaceuticals plcS Sale	Director	SSale	−2,000 sh	$152.88	−$306K	0
2022-08-08	JAZZJazz Pharmaceuticals plcS Sale	Director	SSale	−1,089 sh	$152.33	−$166K	24,086

Recent filings

Accepted (ET)
Sep 24
ENRIGHT PATRICK G0001253886-26-000011
SEC(opens sec.gov)
Aug 74
ENRIGHT PATRICK G0001253886-26-000008
SEC(opens sec.gov)
Jun 174
ENRIGHT PATRICK G0001104659-26-075251
SEC(opens sec.gov)
Jun 124
ENRIGHT PATRICK G0001253886-26-000006
SEC(opens sec.gov)
May 264
ENRIGHT PATRICK G0001253886-26-000004
SEC(opens sec.gov)
Feb 54
ENRIGHT PATRICK G0001628280-26-005904
SEC(opens sec.gov)
Jan 84
ENRIGHT PATRICK G0001253886-26-000002
SEC(opens sec.gov)
Dec 154
ENRIGHT PATRICK G0001193125-25-319649
SEC(opens sec.gov)
Oct 144
ENRIGHT PATRICK G0001193125-25-238326
SEC(opens sec.gov)
Aug 114
ENRIGHT PATRICK G0001765581-25-000092
SEC(opens sec.gov)

Insider transactions

Recent filings

Companies

Address